Retractable Technologies, Inc. RVP
Retractable Technologies, Inc. (NYSE: RVP) is a medical device company. Its next catalyst on record is 0.5 mL syringe domestic manufacturing: Commercial quantities of domestically made 0.5 mL syringes expected to become available (H2 2026).
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Next further out: 0.5 mL syringe domestic manufacturing — Commercial quantities of domestically made 0.5 mL syringes expected to become available (H2 2026). 1 catalyst on record beyond the next 30 days; subscribers see each with its filing sentence.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| VanishPoint syringes | Retractable safety syringes | unclear | NA_NON_THERAPEUTIC |
| EasyPoint retractable needles | Retractable safety needles | unclear | NA_NON_THERAPEUTIC |
| IV safety catheter and blood collection products | Safety medical products | unclear | NA_NON_THERAPEUTIC |
| Unnamed safety product submitted to FDA | Not stated | unclear | NA_NON_THERAPEUTIC |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.